VANGUARD GROUP INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$35,944,839
-23.0%
1,406,843
-13.6%
0.00%0.0%
Q2 2023$46,702,971
+33.0%
1,628,416
+11.1%
0.00%0.0%
Q1 2023$35,124,343
+42.8%
1,465,346
+1.0%
0.00%0.0%
Q4 2022$24,599,207
+24.2%
1,450,425
+8.5%
0.00%0.0%
Q3 2022$19,812,000
+5.5%
1,336,818
+12.0%
0.00%0.0%
Q2 2022$18,787,000
-39.6%
1,193,656
+3.5%
0.00%0.0%
Q1 2022$31,099,000
-26.8%
1,153,513
+0.5%
0.00%0.0%
Q4 2021$42,458,000
-20.2%
1,147,222
+3.0%
0.00%0.0%
Q3 2021$53,225,000
+33.3%
1,113,951
-5.6%
0.00%0.0%
Q2 2021$39,926,000
-19.3%
1,179,841
-1.5%
0.00%0.0%
Q1 2021$49,452,000
-3.6%
1,197,380
+1.3%
0.00%0.0%
Q4 2020$51,292,000
+15.3%
1,182,382
+14.0%
0.00%0.0%
Q3 2020$44,495,000
+9.3%
1,037,177
+19.1%
0.00%0.0%
Q2 2020$40,708,000
+1986.5%
870,935
+506.6%
0.00%
Q1 2020$1,951,000
+44.8%
143,581
+15.9%
0.00%
Q4 2019$1,347,000
+5.9%
123,8810.0%0.00%
Q3 2019$1,272,000123,8810.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders